BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35257298)

  • 1. Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review.
    Guirado M; Fernández Martín E; Fernández Villar A; Navarro Martín A; Sánchez-Hernández A
    Clin Transl Oncol; 2022 Aug; 24(8):1549-1568. PubMed ID: 35257298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review.
    Jacobsen MM; Silverstein SC; Quinn M; Waterston LB; Thomas CA; Benneyan JC; Han PKJ
    Lung Cancer; 2017 Oct; 112():156-164. PubMed ID: 29191588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delays for diagnosis and treatment of lung cancers: a systematic review.
    Vinas F; Ben Hassen I; Jabot L; Monnet I; Chouaid C
    Clin Respir J; 2016 May; 10(3):267-71. PubMed ID: 25308518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delays to diagnosis and treatment of lung cancer in Australia: healthcare professional perceptions of actual versus acceptable timeframes.
    Malalasekera A; Dhillon HM; Blinman PL; Kao SC; Vardy JL
    Intern Med J; 2018 Sep; 48(9):1063-1071. PubMed ID: 29756277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
    Vinod SK; Chandra A; Berthelsen A; Descallar J
    Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of delays during diagnosis and management of lung cancer in India: A prospective observational study.
    Garg A; Iyer H; Jindal V; Vashistha V; Chawla G; Tiwari P; Mittal S; Madan K; Hadda V; Guleria R; Sati HC; Mohan A
    Eur J Cancer Care (Engl); 2022 Sep; 31(5):e13621. PubMed ID: 35668033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How long is too long? A scoping review of health system delays in lung cancer.
    Malalasekera A; Nahm S; Blinman PL; Kao SC; Dhillon HM; Vardy JL
    Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30158277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study.
    Vidaver RM; Shershneva MB; Hetzel SJ; Holden TR; Campbell TC
    J Oncol Pract; 2016 Jun; 12(6):e643-53. PubMed ID: 27143146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of delay on diagnosis and treatment of primary lung cancer.
    Jensen AR; Mainz J; Overgaard J
    Acta Oncol; 2002; 41(2):147-52. PubMed ID: 12102158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing Bottlenecks to Improve the Efficiency of the Lung Cancer Care Delivery Process: A Process Engineering Modeling Approach to Patient-Centered Care.
    Ju F; Lee HK; Yu X; Faris NR; Rugless F; Jiang S; Li J; Osarogiagbon RU
    J Med Syst; 2017 Dec; 42(1):16. PubMed ID: 29196866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waiting Time Intervals for Non-small Cell Lung Cancer Diagnosis and Treatment in Alberta: Quantification of Intervals and Identification of Risk Factors Associated with Delays.
    Kim JO; Davis F; Butts C; Winget M
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):750-759. PubMed ID: 27357099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are we achieving the current waiting time targets in lung cancer treatment? Result of a prospective study from a large United kingdom teaching hospital.
    Devbhandari MP; Bittar MN; Quennell P; Barber P; Krysiak P; Shah R; Jones MT
    J Thorac Oncol; 2007 Jul; 2(7):590-2. PubMed ID: 17607113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures.
    Stokstad T; Sørhaug S; Amundsen T; Grønberg BH
    BMC Health Serv Res; 2019 Sep; 19(1):679. PubMed ID: 31533705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012].
    Pourcel G; Ledesert B; Bousquet PJ; Ferrari C; Viguier J; Buzyn A
    Bull Cancer; 2013 Dec; 100(12):1237-50. PubMed ID: 24158562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes.
    Zhang J; IJzerman MJ; Oberoi J; Karnchanachari N; Bergin RJ; Franchini F; Druce P; Wang X; Emery JD
    Lung Cancer; 2022 Apr; 166():27-39. PubMed ID: 35152171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer interval times from point of referral to the acute health sector to the start of first treatment.
    Largey G; Ristevski E; Chambers H; Davis H; Briggs P
    Aust Health Rev; 2016 Jan; 40(6):649-654. PubMed ID: 26909516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timeliness of care and prognosis in patients with lung cancer.
    Gonzalez-Barcala FJ; Falagan JA; Garcia-Prim JM; Valdes L; Carreira JM; Puga A; Martín-Lancharro P; Garcia-Sanz MT; Anton-Sanmartin D; Canive-Gomez JC; Pose-Reino A; Lopez-Lopez R
    Ir J Med Sci; 2014 Sep; 183(3):383-90. PubMed ID: 24091615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study.
    Forrest LF; Adams J; White M; Rubin G
    Br J Cancer; 2014 Oct; 111(9):1843-51. PubMed ID: 25203519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Times to Diagnosis and Treatment of Lung Cancer in New South Wales, Australia: A Multicenter, Medicare Data Linkage Study.
    Malalasekera A; Blinman PL; Dhillon HM; Stefanic NA; Grimison P; Jain A; D'Souza M; Kao SC; Vardy JL
    J Oncol Pract; 2018 Oct; 14(10):e621-e630. PubMed ID: 30207854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timeliness of cancer care in a regional Victorian health service: A comparison of high-volume (Lung) and low-volume (oesophagogastric) tumour streams.
    Kabwe M; Robinson A; Shethia Y; Parker C; Blum R; Solo I; Leach M
    Cancer Rep (Hoboken); 2021 Feb; 4(1):e1301. PubMed ID: 33026194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.